These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26042529)

  • 1. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.
    Matos MJ; Vilar S; Kachler S; Celeiro M; Vazquez-Rodriguez S; Santana L; Uriarte E; Hripcsak G; Borges F; Klotz KN
    Bioorg Chem; 2015 Aug; 61():1-6. PubMed ID: 26042529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.
    Matos MJ; Vilar S; Kachler S; Fonseca A; Santana L; Uriarte E; Borges F; Tatonetti NP; Klotz KN
    ChemMedChem; 2014 Oct; 9(10):2245-53. PubMed ID: 25044491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
    Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of
    Vazquez-Rodriguez S; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F; Matos MJ
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel pyridazinone-based adenosine receptor ligands.
    Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Colotta V
    Bioorg Med Chem Lett; 2018 May; 28(9):1484-1489. PubMed ID: 29627261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships.
    Fonseca A; Matos MJ; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F
    Chem Biol Drug Des; 2018 Jan; 91(1):245-256. PubMed ID: 28734062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay.
    Vincenzi M; Bednarska K; Leśnikowski ZJ
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30044380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
    Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
    Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
    van Westen GJ; van den Hoven OO; van der Pijl R; Mulder-Krieger T; de Vries H; Wegner JK; Ijzerman AP; van Vlijmen HW; Bender A
    J Med Chem; 2012 Aug; 55(16):7010-20. PubMed ID: 22827545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
    Manetti F; Schenone S; Bondavalli F; Brullo C; Bruno O; Ranise A; Mosti L; Menozzi G; Fossa P; Trincavelli ML; Martini C; Martinelli A; Tintori C; Botta M
    J Med Chem; 2005 Nov; 48(23):7172-85. PubMed ID: 16279775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Optimization of Coumarin hA
    Matos MJ; Vilar S; Vazquez-Rodriguez S; Kachler S; Klotz KN; Buccioni M; Delogu G; Santana L; Uriarte E; Borges F
    J Med Chem; 2020 Mar; 63(5):2577-2587. PubMed ID: 31738058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of N⁶-substituted apioadenosines as potential adenosine A₃ receptor modulators.
    Toti KS; Moss SM; Paoletta S; Gao ZG; Jacobson KA; Van Calenbergh S
    Bioorg Med Chem; 2014 Aug; 22(15):4257-68. PubMed ID: 24931275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-[9-(ortho-fluorobenzyl)-2-phenyl-8-azapurin-6-yl]-amides as potent and selective ligands for A₁ adenosine receptors.
    Borghini A; Pietra D; Leonardi M; Giorgi I; Bianucci AM
    Chem Biol Drug Des; 2013 Jul; 82(1):22-38. PubMed ID: 23480235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A
    Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V
    Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.
    Squarcialupi L; Falsini M; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Volpini R; Colotta V
    Bioorg Med Chem; 2016 Jun; 24(12):2794-808. PubMed ID: 27161878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
    Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.